Cost-Effectiveness Of Intranasal Interferon Gamma For Inpatient Treatment Of Influenza

[摘要] Influenza is one of the most prevalent and socially significant upper respiratory tract infections.Themajority of patients suffer from its mild form; medium and severe forms of the disease may be associated withcomplications, and hospitalization is often required for such patients. The pharmacoeconomic evaluationdemonstrated the benefit of the use of intranasal recombinant interferon gamma (Ingaron) in a combinedtherapy of influenza in hospital. The inclusion of Ingaron into the therapy of influenza reduces the duration ofthe disease and the length of hospital stay. The economic effect of the administration of Ingaron includesbudget savings for the health care system of Russia and improved life quality of patients.

[学科分类] 工程和技术（综合）

[关键词] interferon gamma;influenza;QALY;budget impact.